Source:http://linkedlifedata.com/resource/pubmed/id/17958775
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2007-10-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0002-9270
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2612-3
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17958775-Antiviral Agents,
pubmed-meshheading:17958775-Hepatitis C, Chronic,
pubmed-meshheading:17958775-Humans,
pubmed-meshheading:17958775-Interferon-alpha,
pubmed-meshheading:17958775-Male,
pubmed-meshheading:17958775-Middle Aged,
pubmed-meshheading:17958775-Recombinant Proteins,
pubmed-meshheading:17958775-Retinal Diseases
|
pubmed:year |
2007
|
pubmed:articleTitle |
Continued treatment of chronic hepatitis C despite development of interferon-associated retinopathy.
|
pubmed:publicationType |
Letter,
Case Reports
|